138 related articles for article (PubMed ID: 15520222)
1. Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.
Tourneur L; Delluc S; Lévy V; Valensi F; Radford-Weiss I; Legrand O; Vargaftig J; Boix C; Macintyre EA; Varet B; Chiocchia G; Buzyn A
Cancer Res; 2004 Nov; 64(21):8101-8. PubMed ID: 15520222
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
3. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
4. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
5. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
6. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia.
Min YJ; Lee JH; Choi SJ; Chi HS; Lee JS; Kim WK; Lee KH
Leuk Res; 2004 Apr; 28(4):359-65. PubMed ID: 15109535
[TBL] [Abstract][Full Text] [Related]
8. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B
J Clin Oncol; 2009 Nov; 27(33):5580-6. PubMed ID: 19858393
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
Baader E; Toloczko A; Fuchs U; Schmid I; Beltinger C; Ehrhardt H; Debatin KM; Jeremias I
Cancer Res; 2005 Sep; 65(17):7888-95. PubMed ID: 16140959
[TBL] [Abstract][Full Text] [Related]
10. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
11. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
12. Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells.
Tourneur L; Mistou S; Michiels FM; Devauchelle V; Renia L; Feunteun J; Chiocchia G
Oncogene; 2003 May; 22(18):2795-804. PubMed ID: 12743602
[TBL] [Abstract][Full Text] [Related]
13. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules.
Park SM; Schickel R; Peter ME
Curr Opin Cell Biol; 2005 Dec; 17(6):610-6. PubMed ID: 16226446
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.
Vondrácek J; Soucek K; Sheard MA; Chramostová K; Andrysík Z; Hofmanová J; Kozubík A
Leuk Res; 2006 Jan; 30(1):81-9. PubMed ID: 15998540
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
[TBL] [Abstract][Full Text] [Related]
17. Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
Riccioni R; Senese M; Diverio D; Riti V; Mariani G; Boe A; LoCoco F; Foà R; Peschle C; Sporn M; Testa U
Leuk Res; 2008 Aug; 32(8):1244-58. PubMed ID: 18304628
[TBL] [Abstract][Full Text] [Related]
18. Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms.
Blomberg J; Ruuth K; Santos D; Lundgren E
Anticancer Res; 2008; 28(2A):593-9. PubMed ID: 18506997
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure.
Schuchmann M; Varfolomeev EE; Hermann F; Rueckert F; Strand D; Koehler H; Strand S; Lohse AW; Wallach D; Galle PR
Hepatology; 2003 Jan; 37(1):129-35. PubMed ID: 12500197
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
Heuser M; Wingen LU; Steinemann D; Cario G; von Neuhoff N; Tauscher M; Bullinger L; Krauter J; Heil G; Döhner H; Schlegelberger B; Ganser A
Haematologica; 2005 Nov; 90(11):1484-92. PubMed ID: 16266895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
